144 related articles for article (PubMed ID: 15906108)
1. Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.
Waern JB; Harris HH; Lai B; Cai Z; Harding MM; Dillon CT
J Biol Inorg Chem; 2005 Aug; 10(5):443-52. PubMed ID: 15906108
[TBL] [Abstract][Full Text] [Related]
2. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
3. A (1)H NMR study of the interaction of antitumor metallocenes with glutathione.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Sep; 86(2-3):611-6. PubMed ID: 11566334
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils.
Buck DP; Abeysinghe PM; Cullinane C; Day AI; Collins JG; Harding MM
Dalton Trans; 2008 May; (17):2328-34. PubMed ID: 18414758
[TBL] [Abstract][Full Text] [Related]
5. Organometallic anticancer agents: the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents.
Murray JH; Harding MM
J Med Chem; 1994 Jun; 37(13):1936-41. PubMed ID: 8027975
[TBL] [Abstract][Full Text] [Related]
6. Spermicidal activity of metallocene complexes containing vanadium(IV) in humans.
D'Cruz OJ; Ghosh P; Uckun FM
Biol Reprod; 1998 Jun; 58(6):1515-26. PubMed ID: 9623614
[TBL] [Abstract][Full Text] [Related]
7. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
8. Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.
Köpf-Maier P; Krahl D
Chem Biol Interact; 1983 Jun; 44(3):317-28. PubMed ID: 6872095
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of bent metallocenes: electronic structure analysis using DFT computations.
Senthilnathan D; Vaideeswaran S; Venuvanalingam P; Frenking G
J Mol Model; 2011 Mar; 17(3):465-75. PubMed ID: 20495841
[TBL] [Abstract][Full Text] [Related]
10. Antitumour metallocenes: structure-activity studies and interactions with biomolecules.
Harding MM; Mokdsi G
Curr Med Chem; 2000 Dec; 7(12):1289-303. PubMed ID: 11032972
[TBL] [Abstract][Full Text] [Related]
11. Coordination chemistry of the antitumor metallocene molybdocene dichloride with biological ligands.
Waern JB; Harding MM
Inorg Chem; 2004 Jan; 43(1):206-13. PubMed ID: 14704069
[TBL] [Abstract][Full Text] [Related]
12. Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters.
Erxleben A; Claffey J; Tacke M
J Inorg Biochem; 2010 Apr; 104(4):390-6. PubMed ID: 20036426
[TBL] [Abstract][Full Text] [Related]
13. Electronic structure of bent titanocene complexes with chelated dithiolate ligands.
Cooney JJ; Cranswick MA; Gruhn NE; Joshi HK; Enemark JH
Inorg Chem; 2004 Dec; 43(25):8110-8. PubMed ID: 15578851
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity and transmission electron microscopy studies of molybdocene dichloride.
Campbell KS; Foster AJ; Dillon CT; Harding MM
J Inorg Biochem; 2006 Jul; 100(7):1194-8. PubMed ID: 16527357
[TBL] [Abstract][Full Text] [Related]
15. Organometallic anticancer agents. 2. Aqueous chemistry and interaction of niobocene dichloride with nucleic acid constituents and amino acids.
Harding MM; Prodigalidad M; Lynch MJ
J Med Chem; 1996 Dec; 39(25):5012-6. PubMed ID: 8960562
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
Stachtea X; Karamanos N; Klouras N
Anticancer Res; 2009 Aug; 29(8):3227-31. PubMed ID: 19661339
[TBL] [Abstract][Full Text] [Related]
17. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
18. Cytocompatibility of pure metals and experimental binary titanium alloys for implant materials.
Park YJ; Song YH; An JH; Song HJ; Anusavice KJ
J Dent; 2013 Dec; 41(12):1251-8. PubMed ID: 24060476
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
20. P-S Bond scission by bis(cyclopentadienyl)molybdenum(IV) dichloride, Cp(2)MoCl(2)(aq): first documented example of an organometallic complex hydrolyzing thiophosphinates.
Kuo LY; Blum AP; Sabat M
Inorg Chem; 2005 Jul; 44(15):5537-41. PubMed ID: 16022553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
